Skip to main content

Gastrointestinal Cancer: Current Screening Strategies

  • Chapter
  • First Online:
Inflammation and Gastrointestinal Cancers

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 185))

Abstract

The prevention and chemoprevention of cancer is based on identifying a pre-neoplastic lesion and altering the outcome by early intervention. Many of the gastrointestinal epithelial cancers are related to chronic inflammatory conditions for many years prior to cancer development. It is clear that treatment of the inflammatory condition can prevent and indeed reverse changes that predispose to cancer. This is most notable for helicobacter pylori infection of the stomach. Screening for Barrett’s oesophagus and other conditions are more controversial and the results of large scale clinical trials are awaited. Nevertheless preventive strategies are highly attract health care interventions and are being actively considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Allum WH, Griffin SM, Watson A, Colin-Jones D (2002) Guidelines for the management of oesophageal and gastric cancer. Gut 50 (suppl V):v1–v23

    Google Scholar 

  • Barr H (2008) Squamous cell carcinoma of the oesophagus. In: Jankowski J, Sampliner RE, Kerr DJ, Fung Y (eds) Gastrointestinal oncology: a critical multidisciplinary team approach. Oxford University Press, Oxford

    Google Scholar 

  • Bini EJ, Green B, Poles MA (2009) Screening colonoscopy for detection of neoplastic lesions in asymptomatic HIV-infected subjects. Gut 58:1129–1134

    Article  PubMed  CAS  Google Scholar 

  • Brown L, Devesa S, Chow WH (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100:1184–1187

    Article  PubMed  Google Scholar 

  • Cairns S, Scholefield JH (2002) Guidelines for colorectal cancer screening in high risk groups. Gut 51(Suppl V):v1–v2

    Article  PubMed  Google Scholar 

  • Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohns disease. Aliment Pharmacol Ther 23:1097–1104

    Article  PubMed  CAS  Google Scholar 

  • Choi KS, Kwak M-S, Lee H-Y, Jun JK, Hahm M, Par E-C (2009) Screening for gastric cancer in Korea: population-based preferences for endoscopy versus upper gastrointestinal series. Cancer Epidemiol Biomarkers Prev 18:1390–1398

    Article  PubMed  Google Scholar 

  • Clemons NJ, McColl KE, Fitzgerald R (2007) Nitric oxide and acid induce double-strand DNA breaks in Barrett’s carcinogenesis via distinct mechanisms. Gastroenterology 133:1198–1209

    Article  PubMed  CAS  Google Scholar 

  • Das D, Ishaq S, Harrison R, Kosuri K, Harper E, deCaestecker J, Sampliner R, Barr H, Watson P, Moayyedi PJ, Jankowski J (2008) Management of Barrett’s esophagus in the UK: over treated and under biopsied but improved by the introduction of a national randomised trial. AJG 103:1079–1089

    Article  PubMed  Google Scholar 

  • Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis:a meta-analysis. Gut 48:526–535

    Article  PubMed  CAS  Google Scholar 

  • Ekbom A, Helmick C, Zack M et al (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228–1233

    Article  PubMed  CAS  Google Scholar 

  • Fernando HC, Murthy SC, Hofstetter W et al (2009) The society of thoracic surgeons practice guideline series: Guidelines for the management of Barrett’s esophagus with high-grade dysplasia. Ann Thorac Surg 87:1993–2002

    Article  PubMed  Google Scholar 

  • Friedman S (2006) Cancer in Crohns disease. Gastroenterol Clin N Am 35:621–639

    Article  Google Scholar 

  • Fukase K, Kato M, Kikuchi S et al (2008) Effect of eradication of helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic restion of gastric cancer: an open-label, randomised controlled trial. Lancet 372:392–397

    Article  PubMed  Google Scholar 

  • Graham DY, Shiotani A (2005) The time to eradicate gastric cancer is now. Gut 54:735–738

    Article  PubMed  CAS  Google Scholar 

  • Grosjean P, Monnier P (1998) Photodynamic therapy and mucosectomy for early squamous cell carcinomas in the oesophagus and tracheobronchial tree. Eur J Surg Oncol 24:234

    Google Scholar 

  • Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T (2008) The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 38:259–267

    Article  PubMed  Google Scholar 

  • Heath EI, Canto MI, Piantadosi S et al (2007) Secondary chemoprevention of Barrett’s esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst 99:545–557

    Article  PubMed  CAS  Google Scholar 

  • Jankowski J, Barr H (2006) Improving surveillance for Barrett’s oesophagus: AspECT and BOSS trials provide an evidence base. BMJ 332:1512

    Article  PubMed  Google Scholar 

  • Jankowski J, Hawk E (2006) A methodological analysis of chemoprevention in the gastrointestinal tract. Nat Clin Pract Gastro Hep 3:101–111

    Article  CAS  Google Scholar 

  • Jess T, Loftus E, Velayos F et al (2006) Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted, Minnesota. Gastroenterology 130:1039–1046

    Article  PubMed  Google Scholar 

  • Katz P (2008) Esophageal carcinoma and achalasia: another call for screening? Achalasia complicated by squamous cell carcinoma: A prospective study in 195 patients. AJG 88:783–793

    Google Scholar 

  • Konda A, Duffy MC (2008) Surveillance of patients at increased risk of colorectal cancer: inflammatory bowel disease and other conditions. Gastroenterol Clin N Am 37:191–213

    Article  Google Scholar 

  • Lagergren J, Bergstrom R, Lindgren A, Myren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 18:825–831

    Article  Google Scholar 

  • Leung WK, Wu M, Kakugawa Y et al (2008) Screening for gastric cancer: current evidence and practice. Lancet Oncol 9:279–287

    Article  PubMed  Google Scholar 

  • Logan RFA (2009) Malignancy in unrecognised coeliac disease: a nail in the coffin for mass screening? Gut 58:618–619

    Article  PubMed  Google Scholar 

  • Lohi S, Mäki M, Montonen J, Knekt P, Pukkala E, Reunanen A, Kaukinen K (2009) Malignancies in cases with screening—identified evidence of celiac disease: a long-term population-based cohort study. Gut 58:643–647

    Article  PubMed  CAS  Google Scholar 

  • Marx J (2004) Inflammation and cancer: the link grows stronger. Science 306:966–968

    Article  PubMed  CAS  Google Scholar 

  • Quante M, Wang TC (2008) Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology 23:350–359

    Article  PubMed  CAS  Google Scholar 

  • Raj A, Jankowski J (2004) Acid suppression and chemoprevention in Barrett’s oesophagus. Dig Dis 22:171–180

    Article  PubMed  Google Scholar 

  • Rieger MA, Hoppe PS, Smejkal BM, Eitelhuber AC, Schroeder T (2009) Hematopoietic cytokines can instruct lineage choice. Science 325:217–218

    Article  PubMed  CAS  Google Scholar 

  • Rubin DT, Kavitt RT (2006) Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin N Am 35:581–604

    Article  Google Scholar 

  • Sandler RS, Nyren O, Ekhom A et al (1992) The risk of esophageal cancer in patients with achalasia: a population based study. JAMA 274:1359–1362

    Article  Google Scholar 

  • Soetikno RM, Lin OS, Heidenreich PA et al (2002) Increased risk of colorectal neoplasia in patients with primary sclersoing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56:48–54

    Article  PubMed  Google Scholar 

  • Suzuki H, Iijima K, Scobie C, Fyfe V, Mc Coll KEL (2005) Nitrate and nitrosative chemistry within Barrett’s oesophagus during acid reflux. Gut 54:1527–1535

    Article  PubMed  CAS  Google Scholar 

  • Tomizawa Y, Wang KK (2009) Screening, surveillance, and prevention for esophageal cancer. Gastroenterol Clin N Am 38:59–73

    Article  Google Scholar 

  • Velayos FS, Loftus EV Jr, Jess T et al (2006) predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-controlled study. Gastroenterology 130:1941–1949

    Article  PubMed  Google Scholar 

  • Wang K, Sampliner R (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. AJG 103:788–797

    Article  PubMed  Google Scholar 

  • Watabe H, Mitsushima T, Yamaji Y et al (2005) Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 54:764–768

    Article  PubMed  CAS  Google Scholar 

  • Wong A, Fitzgerald RC (2005) Epidemiologic risk factors for Barrett’s esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 3:1–10

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hugh Barr .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Velag Berlin Heidelberg

About this chapter

Cite this chapter

Barr, H. (2011). Gastrointestinal Cancer: Current Screening Strategies. In: Jankowski, J. (eds) Inflammation and Gastrointestinal Cancers. Recent Results in Cancer Research, vol 185. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03503-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-03503-6_9

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-03502-9

  • Online ISBN: 978-3-642-03503-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics